Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3835845 A
Publication typeGrant
Publication dateSep 17, 1974
Filing dateOct 24, 1972
Priority dateOct 24, 1972
Publication numberUS 3835845 A, US 3835845A, US-A-3835845, US3835845 A, US3835845A
InventorsC Maher
Original AssigneeMedical Innovations Inc
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Cardiac synchronization system and method
US 3835845 A
Abstract
Improved internal circulatory assist apparatus comprising control means whereby the optimum synchronization of the assist apparatus with the beat of the heart can be effectively achieved while using any of a plurality of parts of the body as monitor sites for obtaining an arterial signal representative of the patient's heartbeat. The control means consists of a marker means, such as a pip on an oscilloscope, which is adjustable by variable-delay circuitry throughout a range equal to the time difference between the sensing of a selected cardiac event at an earliest-reacting monitoring site and the sensing of a selected cardiac event at a later-reacting monitoring site.
Images(3)
Previous page
Next page
Claims  available in
Description  (OCR text may contain errors)

United States Patent Maher CARDIAC SYNCHRONIZATION SYSTEM AND METHOD IIII 3,835,845

[ Sept. 17, 1974 [75] Inventor: Charles E. Maher, Brockton, Mass. MCKenna; Andrew Kehoe [73] Assignee: xiii-cal Innovations, Inc., Waltham, ABSTRACT [22] Filed: Oct 24 1972 Improved internal circulatory assist apparatus comprising control means whereby the optimum synchro- [21] Appl. No.: 300,290 nization of the assist apparatus with the beat of the heart can be effectively achieved while using any of a [52] Us. CL 128/64 28/2 05 R 128/2 06 R plurality of parts of the body as monitor sites for ob- [51 1 Int Cl A6lh' 9/00 taining an arterial signal representative of the patients [58] Field P 205 R heartbeat. The control means consists of a marker 128/2 O6 i 5 means, such as a pip on an oscilloscope, which is adjustable by variable-delay circuitry throughout a range [56] References Cited equal to the time difference between the sensing of a selected cardiac event at an earliest-reacting monitor- UNITED STATES PATENTS ing site and the sensing of a selected cardiac event at Becker R a later reacting monitoring site 3,734,087 5/1973 Sauer et al 128/64 8 Claims, 4 Drawing Figures TO 9O l WATER EMPTY /62 64 68 FROM"2 EMPTY PUMP PRESSURE SENSOR CONTROL DELAY I j DURATION CONTROL CONTROL 89 84 I96 w I PRESSURE V Q QQE DELAY DURATION 2g??? GENERATOR 0 E T GENERATOR 80 ms. l0 DELAY "4 MARKER POSITION i CONTROL 0| 40 ms. DUAL TRACE OSCILLOSCOPE DELAY I EKG TRACE I16 99 I03 203 2 R & w VARIABLE VARIABLE ARTERIAL -EH a PRESSURE INTENSITY INTE \ISITY 2 2 IN CONTROL CONTROL TRACE l TRACE 2 {H8 D +8OmS. ECG TRACE MARKER GENERATOR 56" 1 {J PULSE I20 MIXER M m" PAIENTEB 71974 3.835.845

SHEET 1 [IF 3 II II DESIRED PRESSURE FROM 88 WAVEFORM 22 /9O 34 35 WAVEFORM m fbw GENERATOR WAVEFORM 92 COMPARATOR HYDRAULIC 7 CYLINDER ERROR SIGNAL 8O SERVO a2 STROBE SI AL v AMPLIFIER {FROM 89 LEvEL L SENSOR SERvO id i vA LvE LEVEL COMPARATOR 9 98 ,,ONE SHOT I f OIL RESERVOIR ACCuMuLATOR I v S/ ONE SHOT I vALvE RESERVOIR L FILL FMPTY PUMP PUMP I OFF. H20 69 [PUMP CONTROL VALVE CIRCUIT FROM "68 E H2O L60 FIG.|

F I G. 2

P u SEP I 71874 SHEET 2 [IF 3 E .E. .E

1 WATER EMPTY /-62 64 68 FROM"2 E EEEEEUEE ggg gg SENSOR DELAY DURATION cONTROL CONTROL 1 I I LEvEL yggy; J1 DELAY L %%%%+fi GENERATOR D| GEN%:ATOR GENERATOR 80 ms. /HO DELAY I22 MARKER POSITION Q CONTROL 1 I lo] 40 ms. DuAL. TRACE OSOILLOSOOPE/ r DELAY EKG TRACE Q6 99 VARIABLE VAFEIABLE ARTERIAL PRESSURE INTENSITY INTENsITY 2 2 IN OONTROL CONTROL TRAcE I TRAcE 2 Ila D +80 ms. g ECG TRACE MARKER GENERATOR TO "56" r PULSE I2O NIIxER PAIEIIIIINIIIT I 3.835.845

SHEEI 3 OF 3 -TRIGGERING SIGNAIL I I l I 409 LLI I I 3; I00 I I I 80 I I .l

60 I I 3 40 I I I DELAY TIME To LEG 5 20 I I KIPRESSURIZATION E O I DI .I I I 405\ -D4 YI I I 4o4\ I I I I [NF/O ms. I FTIME HEART wAvE I l 415 A ms SENSED AT wRIsT TIME FOR wAvE TO I REACH HEART I I HMISTART OF DIASTOLE (EKG) I I 403 START OF DIASTOLE I I- (WRIST) ECG I I I; I I I I I I II I I I 0 80 I60 240 320 400 480 560 e40 720 800 880 F I G 3 TIME (MILLISECONDS) I I I I I DIASTOLE (FINGER) -4I5 I I I I l I I CHANNEL I ECG ALTERNATE I "211%;

cENTRAL AoRTA I 42 O ALTERNATE 2 1212551275255 CHANNEL 2 ALTERNATE 3 ARTERIAL CARDIAC SYNCHRONIZATION SYSTEM AND METHOD BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to a novel apparatus for assisting blood flow in the circulatory system by synchronizing the pulsing of an external-assist means with the heartbeat and particularly relates to a novel synchronization-control system for use with the aforesaid appara- H15.

2. Background of the Invention Methods for atraumatically assisting blood circulation of patients have been described in the art. In U.S. Pat. No. 3,303,841 to Dennis, a process is described whereby an external compressing of the lower part of the body expresses a volume of blood larger than the volume of blood pumped in a single stroke of the heart. The blood so expressed is forced back into the aorta and greater arterial vessels and thereby allows a reduction in ventricular workload while maintaining a satisfactory perfusion of blood during ventricular diastole. This general type of process has been elaborated upon in an article entitled Synchronous Assisted Circulation by Birtwell et al., appearing in The Canadian Medical Association Journal (Vol. 95, pages 652-664) on Sept. 24, 1966. In general, synchronous external pressure assist processes are distinguishable and advantageous over pre-existing counter-pulsation processes because the latter kind of procedure involves the cannulation of a major artery, use of an extra-corporeal blood handling device, the use of stringently sterile techniques and the necessity of administering anticoagulants to the patient. Moreover, the blood trauma or hemolysis produced by extra-corporeal pumping devices limits permissible duration of the assist procedure and compromises the condition of the patient. Finally, these trauma-requiring procedures are not only time consuming, they can present a very significant hazard to many patients, and they increase the risk factor in treating all patients.

In U.S. Pat. No. 3,654,919 to Birtwell, an improved external assist apparatus was described wherein the effective pressure on circulatory passages of the legs could be cycled to valves at or below ambient pressure. This apparatus is a major advance in the art and has been extensively used as a vehicle for evaluating the therapeutic potential of externally assisted circulation. Some results of this work are reported in a paper entitled The Hemodynamic Evaluation of External Counterpulsation in Man by T. J. Ryan et al., and presented at the American Heart Association Scientific Sessions held in Atlatntic City, N.J., during November 1970.

At the present time the external counterpulsation method is the only controlled method of assist which requires no surgical intervention or sterile procedures, no use of anticoagulants or anesthesia, and produces no significant trauma. These factors are most important because they usually allow a much earlier use of the apparatus on a patient in, say, a state of circulatory shock than could be justified if another type of assist apparatus had to be used.

The selective application of positive and negative pressures to the portion of the vascular bed in the legs serves to control directly the volume of blood within that portion of the vascular bed and, hence, the pressures within the arterial system, particularly the pressures of the aorta. It is these controlled changes in aortic pressure that lead directly to a reduction in cardiac work, to increased perfusion of the systemic circulation, and to preferential perfusion of the myocardium.

An improved system for providing the desired synchronization of the heartbeat and the external assist apparatus has been developed more recently. That system utilized a feedback signal from the external pressurization of the legs, directly compared this signal to a control signal representative of the desired waveform for treatment of the patient and used an error signal derived from the difference between the aforesaid feedback signal and the control signal to achieve an adjustment of the pressurization to the desired waveform. This pressurization, if not properly timed with respect to the heartbeat, could cause a deleterious, physiological effect on the patient. Therefore, a simple, accurate, automatic phasing means was disclosed, whereby an arterial waveform from the patient is displayed on a multi-channel oscilloscope (or other suitable display device) in conjunction with an elecrocardiographic waveform. The arterial pressure waveform would be obtained at a pre-selected site, for example, at the wrist, and the electrocardiographic waveform is obtained by placement of sensors directly on the torso of the patient proximate the heart.

It takes about milliseconds (ms) for a pressure wave, introduced in the femoral arteries with the apparatus of the invention, to reach the root of the aorta. The subsequent transmission from the root of the aorta to the wrist, where the arterial waveform was typically obtained, takes another ms. It is important that the artificially-induced positive pressure waves be produced in the legs sufficiently before diastole (80 ms) and that the pressure wave reaches the root of the aorta at the beginning of diastole. Therefore the control system of the aforesaid improved apparatus comprises a built-in 80-second delay factor adapting it for use on the pre-selected wrist sensing site.

The start of the augmented diastolic waveform, as seen at the wrist, which results from use of the applicants apparatus, therefore will take place about ms after the pressure is applied to the legs of the patient. In such a situation, it is desirable to have the induced pressure wave initiated by a command signal timed to start 170 ms before the arterial wave, as seen at the wrist indicates the beginning of diastole and 80 ms before the ECG signal indicates the beginning of diastole. The beginning of diastole is indicated in the arterial wave by the so-called dicrotic notch in good approximation by the end of the so-called T-wave which is known to be positive indication of the relaxation of the left ventricle and the end of systole.

In the signal phasing system, the leg pressurization signal was used to intensify the ECG and arterial trace on the oscilloscope after this pressurization signal has been delayed for 80 and 170 ms respectively. The duration of intensification is the duration of each positive pressurization cycle of the leg. With the system, an operator could adjust the delay time until the intensified signal on the ECG or arterial wave fonn is located at the beginning of a diastole. At that point, leg pressurization can be triggered in correct synchronization with the cardiac cycle.

Although the above-described system is generally useful and has been used successfully in some situations, it had the drawback of depending on a predicted constant delay between the aortic event and the selected sensing site. It has now been discovered to be desirable to provide a more versatile means of synchronizing the heartbeat and the apparatus.

SUMMARY OF THE INVENTION Therefore, it is an object of the invention to provide an improved external circulatory assist apparatus.

Another object of the invention is to provide an external circulatory assist device having a synchronizationcontrol means of greater versatility.

Another object of the invention is to provide an apparatus easily synchronized by personnel of moderate skill and training.

A further object of the invention is to provide an improved control means and method which allows the operator of the apparatus to accurately synchronize the apparatus without (1) the necessity of precise prediction of the time delay between the heart action and its effect on the arterial wave sensing site and (2) without predicting the sensing site to be selected.

Other objects of the invention will be obvious to those skilled in the art on their reading this application.

The above objects have been substantially achieved by controlling the synchronization of the external circulatory assist apparatus with a control means whereby the optimum time period between a certain cardiac event (typically the R wave of an ECG curve) and the triggering of the circulatory assist pressure is precisely achieved by a visual and movable indicator means which can be moved during the setting of a time variable, throughout a time range which allows compensation for the time differences between the cardiac event and its manifestation at any arterial-wave sensing site which may be selected at the time of treatment.

The visual marker is advantageously electronic and moved along a channel of an oscilloscope as a trace intensification of a finger plethysmograph, or some like manifestation of a cardiac event, until the marker is positioned at an easily-recognized point on the curve (e.g., at a point indicative of the start of systole).

ILLUSTRATIVE EXAMPLE OF THE INVENTION In this application and accompanying drawings there is shown and described a preferred embodiment of the invention and suggested various alternatives and modifications thereof, but it is to be understood that these are not intended to be exhaustive and that other changes and modifications can be made within the scope of the invention. These suggestions are selected and included for purposes of illustration in order that others skilled in the art will more fully understand the invention and the principles thereof and will be able to modify it in a variety of forms, each as may be best suited in the condition of a particular case.

IN THE DRAWINGS FIGS. 1 and 2, taken together, are a schematic diagram of an external circulatory assist apparatus, including the control means which forms the particular improvement of this invention.

FIG. 3 is a graph illustrating, in real time, the relationship of an electrocardiographic curve and external circulatory assist pressurization.

FIG. 4 is a graph showing curves similar to those which would appear on a two-channel oscilloscope, displaying (I) an electrocardiographic curve and (2) any of several alternative curves manifesting the heartbeat as it is manifested by pressure at the central aorta, a radial artery or a finger.

Referring now to FIGS. 1 and 2, it is seen that a transducer-type pressure sensor 34 including a sensing bladder 35 is utilized to sense hydraulic pressure in bladder 22. If the pressure so sensed is less than 20 millimeters of mercury (mm of Hg), then a pressure-level amplifier 46 will provide an output to the and-type gate 48. If during this low-pressure signal situation, the operator closes a water fill switch 50, he will cause the and gate 48 to transmit a signal which will activate a fill pump 52 through pump control circuit 54 and simultaneously cause a multiposition, solenoid valve 56 to shift to its fill position, i.e., the position allowing water to flow from conduit 58 to conduit 60. Thereupon water will flow into the bladder 22 until a pressure of 20 mm Hg is sensed by pressure sensor 34. The signal from amplifier 46 will then drop consequently closing andgate" 48. Thereupon, fill pump 52 is deactivated and solenoid valve 56 is shifted to its off position.

Water is emptied from bladder 22 by using an analogous system whereby pressure is sensed by sensor 62. In a typical mode of operation, if the pressure sensed is above a minus 15 mm Hg value, a signal is sent to and-gate" 64. If empty switch 66 is closed, the gate 64 will allow a signal command to actuate pump control 68 and empty pump 69 and cause solenoid valve 56 to shift to its empty position, i.e., the position allowing water to flow from conduit 60 to conduit 70 and thence back to water reservoir 72 through 74. The pump 69 will empty until a pressure of less than the illustrative minus 15 mm Hg is sensed. At that time the and-gate" 64 will no longer sense the required signal from sensor 62, and the pump 69 will be turned off and valve 56 will return to its off position.

It is noted that the above-described filling and emptying operations are generally used at the beginning and ending of use and not as continuous control means. Nevertheless it is emphasized that the ability to fill the bladder to a particular pre-determined pressure by automatic means rather than judgement means is highly advantageous.

During operation of the apparatus, the pressure within bladder 34 is maintained at its desired level by adding or removing water from the bladder system as follows:

A displacement sensing type transducer 76 is" mounted on hydraulically-actuated rod .78. Transducer 76 is adapted to provide an electrical signal output pro-.

portional to the linear advance of rod 78 at any given moment.

A normalized value of the position of rod 78 is provided by feeding the signal from transducer 76 intoa by numeral 415 in FIGS. 3 and 4.) Thus when the R wave periodically occurs with each heartbeat, an output is triggered which is fed to a manually controlled delay 86. The purpose of delay 86 is to convert the original signal from first trigger generator 84 to a second time-delayed signal corresponding in real time with the beginning of cardiac diastole. This second signal enters a duration signal generator 88. Generator 88 is so selected that the signal therefrom continues for the length of time that leg pressurization (as caused by pressure in bladder 34) is desired. This signal from generator 88 is fed to level comparator 82 through a level strobe signal generator 89.

The signal from generator 88 is also fed to a waveform generator 90 which produces a wave whose amplitude and shape is analogous to that desired for the leg pressurization sequence. A typical such wave will be trapazoidal-like in shape with a rise of 60 ms, a plateau of 250 ms, and a fall of 60 ms. This wave from generator 90 is fed to a wave form comparator 92 wherein it is continually compared to a signal derived from the actual bladder pressure wave as experienced by sensor 34. The output of comparator 92 is a so-called error signal, i.e., a signal which is indicative of the quality and strength of the difference between the desired wave signal from generator 90 and the actual wave signal from sensor 34.

It is to be noted in reference to waveform generator 90 that a typical generated wave will normally have a total positive pressure period of from about 250 to about 300 milliseconds. The rise and fall in pressure will take about 60 ms each and rise will start about 80 ms before diastole. In general, it is desirable to select a period-determining device which can maintain positive-pressure periods of up to about 500 ms.

The error signal is used to control servo valve 94 through a servo-amplifier 93 and thereby controls the supply of fluid to, and consequently the movement of, hydraulic cylinder 78.

As has been described above, level comparator 82 receives two signals: one, a periodic signal from a duration signal generator 88, via strobe signal generator 89 and the other from displacement level sensor 80. lever comparator 82 compares these two signals, one indicative of the actual position of hydraulic cylinder 78 at a given time. It is the periodic, or strobe signal from duration signal generator 88, as modified by a level strobe signal generator 89, which determines when this comparison is to be made. The comparison is most usefully made at the time platen 30 is in the upper-most portion of its stroke and pressing firmly against bladder 22.

If level comparator 82 senses that the uppermost position of platen 30 is too high, output signal is provided to a one shot (monostable multivibrator) 96. This one shot 96 will then turn on fill pump 52 and also position solenoid valve 56 for a 0.5-second fill period. The 0.5-second fill periods will continue during each cardiac period, (i.e., each heartbeat) until the water volume in bladder 22 is sufficient so that the uppermost position of platen 30 is within an acceptable displacement range at the top of its stroke.

If, on the other hand, the level comparator 82 receives a signal that the uppermost position of platen 30 is too low in its stroke, the uppermost position of empty pump is turned on for one-half second on each cardiac cycle by activation of the one shot device 98 and the empty pump 69. Water is then pumped out of the bladder until the platen achieves a desired rise during its stroke.

The general operation of the system described above is known in the art but is believed to be desirably set forth herein to fully describe the nature of the improved apparatus subject of the invention and the manner in which the operation is phased into correct synchronization with the heartbeat as described below:

A signal from any given arterial pressure-sensing device 99 is fed into a dual trace oscilloscope 101 along with a signal from ECG device 102. These signals appear only as width intensifications 103 of ECG trace 104 and the arterial trace 106.

Before discussing the processing of the ECG and arterial wave signals with respect to the oscilloscope, attention is called to FIG. 3 which shows the relative real timing of the cardiac cycle as represented by electrocardiogram 402, radial arterial pressure waveform 407, and the curve 404, representing the leg pressure rise 405 exerted by the external circulatory assist device on legs of a patient.

The electrocardiograph is characterized by R wave 415, sometimes called a QRS complex, and a T wave 420 see FIG. 4. The beginning of systole is manifested at 399 or about 40 ms after the R wave peak 415. A radial arterial sensing of this heart action will provide a waveform representative of the heart cycle; however, the precise time at which the arterial waveform is sensed, as shown in FIG. 4, will be out of phase with the ECG signal itself by a time dependent on the particular site at which the arterial waveform is sensed. Moreover, a modified waveform, and not the arterial waveform itself, will be sensed at the radial arterial sites. These modified arterial waveforms are characterized by a so-called dicrotic notch 409 which is a manifestation of the beginning of diastole in the cardiac cycle.

In the apparatus described above and known in the prior art, the external assist pressurization, for example at the legs, was to occur at a time (D,) after the triggering signal; milliseconds later the pressure wave reached the heart and after more milliseconds it was sensed at the wrist, the pre-selected sensing site. Thus, the external pressure wave became effective at the heart at the start of diastole as desired. This time corresponds, with reference to an arterial waveform, to the appearance of dicrotic notch 409 on the arterial waveform at the wrist and the apparatus was designed to initiate the pressure pulse at the legs at a time equal to seconds before the manifestation of diastole at the wrist.

A signal from an arterial pressure-sensing device 99 was fed into a dual trace oscilloscope 101 along with a signal from ECG device 102. The duration of an intensification of these signals was the duration of a pressure command signal as receiyed from druation signal gen: erator 88 and appeared as intensifications of ECG trace 104 and arterial trace 106. Delay devices of 90 milliseconds and 80 milliseconds respectively, caused the pressure command signal to appear on both waveforms in approximately correct time relationship referenced to the actual ECG and arterial pressure. D, i.e., variable delay 86 was used to bring the intensification signal into register with the diastolic period as viewed on either the ECG or arterial traces, thereby simultaneously phasing the pressurization wave to the cardiac cycle.

The operator of the apparatus also has variable control means for changing the characteristics of the duration signal generator 88 to provide the intensified signal duration which is required for a particular patient. On the oscilloscope 100, this duration showed up as intensifications 103 of the oscilloscope traces.

This prior control system depended for optimum operation on the pre-selection of a particular arterialsensing site, such as the wrist, which would typically be about 90 milliseconds out of phase with the ECG cycle.

In order to make it possible to avoid pre-selection of a given delay such as the aforesaid 90 milliseconds between the ECG event and the sensing thereof at the wrist, the following system is utilized:

A signal from an ECG device 102 is fed through a trigger generator 84, delay 86, and duration signal generator 88, into an 80 ms delay device 110 as before. The output from device 110, a pulse equal in duration to D is delayed from the R wave by a time D (imparted by delay 86) plus 80 milliseconds. This pulse is used to provide the ECG (Channel 1) intensification.

The pulse is also fed into variable delay device 112, from which-a signal is obtained which is delayed from the R wave by a time equalling D plus 80 milliseconds plus D wherein D is the variable delay imparted by adjustable delay device 112. i

The trigger signal from trigger generator 84, meanwhile, is being fed to a 40-millisecond delay device 114, and thence to a variable delay device 116. The output from device 116 is fed to a marker generator 118, which generates a marker pulse delayed from the R wave by D plus 40 milliseconds wherein D is the variable delay imparted by adjustable delay device 116. The signals from marker generator 118 and delay device 112 are fed into pulse mixer 120 and the resulting signal is fed to the channel 2 trace of the oscilloscope, i.e., that channel showing the arterial waveform.

In operation, a marker pip from generator 118, and illustrated alternatively as 414, 415 or 416 on FIG. 4, depending on the placement of the arterial sensor 99, is moved along arterial trace 106 to a position which is at the start of systole, e.g., as shown at 414. This position is characterized by the start of a fast rise 403 in the arterial trace.

The marker pip can be moved by use of marker position control 122 throughout a range equivalent to the D variable time delay simultaneously achievable with delay devices 112 and 116. As the marker pip is so moved, the intensified trace provided by duration generator 86 and representative of the external assist pressure stroke follows the marker pip but is delayed by an amount D less 40 milliseconds from the marker pip.

In use, the operator of the apparatus will first look at the arterial trace and adjust marker position control 122 and move the marker pip to its desired position, indicative of the start of systole. This time is equal to 40 milliseconds plus the delay imparted by variable delay device 1 16. Next variable delay device 86, i.e., D will be set by adjusting delay control 124 to bring the intensification signal into register with the dicrotic notch, thereby adjusting the time between notch and the intensification signal to a time represented in FIG. 4 by D Finally duration generator 88 is set by adjusting duration control 126 to give the proper pulse length, i.e., as shown by numerals 410, 411, 412 and 413 for ECG,

Central Aorta, radial artery and finger plethysmograph,

respectively, thereby phasing the pressurization wave to the cardiac cycle.

It is also to be understood that the following claims are intended to cover all of the generic and specific features of the invention herein described and all statements of the scope of the invention which might be said to fall therebetween.

What is claimed is:

L'In an external circulatory assist apparatus comprising means to pressurize a portion of a patients body, means to synchronize actuation of said pressurization means on a portion of the body with the heart cycle of a patient being treated, means for creating an arterial waveforms signal representative of said heart cycle, and display means for monitoring a said waveform signal exhibiting a dicrotic notch portion representative of said heart cycle in the form of visible traces on said display means the improvement wherein said synchronizing means includes:

A. means to provide first and second intensified marker pips on said display means displaying a marker trace representative of said arterial waveform derived from a patient,

B. a first means to adjust the position of said first marker pip relative to and along said waveform to a characteristic and identifiable position of arterial waveforms, said adjusting means also forming,

C. means to, concurrently with the adjustment of said first marker pip, move a second intensified pip along said waveform at a constant distance from said first marker, and

D. A second independent adjusting means to bring said intensified trace into register with the dicrotic notch of said waveform, said first and second adjusting means for moving said trace pips further forming variable-time adjusting means and synchronization means between a patients heart cycle and the start of said pressurization of his body.

2. Apparatus as defined in claim 1 wherein said means to provide said second said intensified marker pip comprises means to form an ECG-derived signal, a signal generator, means for triggering said signal generator by said ECG-derived signal, a variable delay means, a marker pip generator, and a pulse mixer for integrating said second marker pip signal with a signal representative of a pressure wave exerted by said external assist apparatus on said patient.

3. Apparatus as described in claim 2 wherein said variable delay means provides a delay variable over a time difference at least equal to the time elapsing from diastole in a patients heart cycle to the time such diastole is registered in said patients digital extremities.

4. Apparatus as defined in claim 1 wherein said position adjusting means provide means to adjust said marker pip over a portion of the waveform equivalent in length to time elapsing from diastole in a patients heart cycle to the time such diastole is registered in said patients digital extremities.

5. In apparatus for applying external pressure assist action to the limbs of a patient in cyclic synchronization with the heartbeat of said patient, wherein said assist is achieved with means for transmitting pressure to said limbs through a fluid-filled bladder pressurizing means surrounding said limbs, means for creating an arterial waveform signal representative of said heartbeat and display means for monitoring a said waveform signal representative of said hearbeat in the form of visible traces on said display means, wherein the apparatus also includes a visual cycle-phasing monitor comprising:

A. a multi-channel display means for displaying 1. an ECG trace, and 2. a trace derived from an arterial pressure sensor,

B. means for visually displaying for the relative time duration of a pressure command signal on said traces, and

C. manual means to adjust the relative timing and duration of said pressure command signal, while simultaneously achieving a visual adjustment of said signal to bring it into the desired relationship to said ECG trace or arterial trace; and means to initi ate said pressure command signal; and wherein said apparatus comprises:

A. means to provide a first marker pip on display apparatus displaying a marker trace representative of a radial arterial waveform derived from a patient,

B. means to adjust the position of said marker pip relative to said waveform to a characteristic and identifiable configuration of arterial waveforms, said adjusting means also forming,

C. means to, form an intensified trace on said waveform,

D. means to move, concurrently with said adjusting, an intensified trace along said waveform at a constant distance from said first marker, and

E. means to bring said intensified trace into register with the dicrotic notch of said waveform, thereby adjusting the synchronization for activating said pressure command signal.

6. In apparatus for applying external pressure assist action to the limbs of a patient in cyclic synchronization with the heartbeat of said patient, wherein said apparatus comprises means for producing a pressure command signal, means for transmitting pressure through a hydraulic cylinder to said limbs through a fluid-filled bladder pressurizing means surrounding said limbs in response to means for activating said pressure command signal, and means for creating an arterial waveform signal representative of said heartbeat and display means for monitoring a said waveform signal representative of said heartbeat in the form of visible traces on said display means, and wherein the apparatus includes A. an ideal pressure waveform generator means,

B. actual limb pressure waveform sensing means,

C. said display means forming means for continually comparing said ideal and actual waveforms, and

D. variable valve means, responsible to a signal from said comparing means, to modify fluid flow to said hydraulic cylinder and thereby to transmit pressure to said limbs through said fluid-filled bladder more nearly achieve said ideal-pressure waveform at said limbs the improvement wherein said apparatus comprises:

A. means to provide a first marker pip on display apparatus displaying a marker trace representative of said arterial waveform derived from a patient,

B. means to adjust the position of said marker pip relative to said waveform to a characteristic and identifiable configuration of arterial waveforms, said adjusting means also forming,

C. means to, form an intensified trace on said waveform,

D. means to move, concurrently with said adjusting, an intensified trace along said waveform at a constant distance from said first marker, and

E. means to bring said intensified trace into register with the dicrotic notch of said waveform, thereby adjusting the synchronization for activating said pressure command signal.

7. Apparatus as defined in claim 6 comprising: A. a multi-channel oscillosopce adapted to display 1. an ECG trace, and

2. a trace derived from an arterial pressure sensor,

B. means for visually displaying of the relative time duration of a pressure command signal on said traces, and

C. manual means to adjust the relative timing and duration of said pressure command signal, while simultaneously achieving a visual adjustment of said signal to bring it into the desired relationship to said ECG trace.

8. In a process for synchronizing a pulsed pressurizing action of an external pressure circulatory assist apparatus with the heartbeat cycle of a patient being treated with said apparatus, said process including the steps of using a display means exhibiting a trace derived from an arterial pressure sensor as a means to judge when said pressurizing action is to be initiated, the improvement comprising the steps of 1. adjusting a reference pip on said arterial trace display means to that portion of said arterial trace which is indicative of the start of the systole rise,

2. simultaneously positioning a second marker pip representative of the time and duration of said pressurization action on said arterial trace proximate and dicrotic notch portion of said trace so that said second pip coincides with the dicrotic notch of said arterial trace, and simultaneously adjusting, through setting a variable time delay means, the synchronization of a patients heartbeat with said pulsed pressurizing action, and

3. adjusting the pulse time of said pressurization action by operating a duration control means which simultaneously expands the second marker pip to form a visual representation of the pulse time on said arterial trace.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3626932 *Oct 11, 1968Dec 14, 1971Hal C BeckerEkg synchronized x-ray double pulse exposure apparatus and method
US3734087 *Nov 11, 1971May 22, 1973Medical Innovations IncExternal pressure circulatory assist
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US4016871 *Mar 6, 1975Apr 12, 1977Peter SchiffElectronic synchronizer-monitor system for controlling the timing of mechanical assistance and pacing of the heart
US4077402 *Jun 25, 1976Mar 7, 1978Benjamin Jr J MalvernApparatus for promoting blood circulation
US4094310 *Oct 4, 1976Jun 13, 1978American Optical CorporationApparatus for enhanced display of physiological waveforms and for defibrillation
US4204524 *Nov 7, 1977May 27, 1980Dov JaronMethod and apparatus for controlling cardiac assist device
US4388919 *Nov 17, 1980Jun 21, 1983Intermedics Cardiassist CorporationRapid stabilization of external cardiac pulsation
US4506658 *Jan 7, 1983Mar 26, 1985Casile Jean PPericardiac circulatory assistance device
US4685461 *Aug 11, 1986Aug 11, 1987Dornier System GmbhApparatus and method for triggering shock waves in lithotripsy
US4745920 *Aug 10, 1987May 24, 1988Dornier System GmbhApparatus and method for triggering therapeutic shock waves
US5000164 *Jun 26, 1989Mar 19, 1991The United States Of America As Represented By The Secretary Of The NavyCirculation enhancing apparatus
US5020516 *Mar 31, 1988Jun 4, 1991Cardiopulmonary CorporationImproving the cardiac output
US5279283 *Aug 11, 1992Jan 18, 1994Dillon Richard SMethod for promoting circulation of blood
US5377671 *Sep 16, 1991Jan 3, 1995Cardiopulmonary CorporationCardiac synchronous ventilation
US5396896 *May 15, 1991Mar 14, 1995Chrono Dynamics, Ltd.Medical pumping apparatus
US5443440 *Jun 11, 1993Aug 22, 1995Ndm Acquisition Corp.Medical pumping apparatus
US5514079 *Jan 13, 1994May 7, 1996Dillon; Richard S.Method for promoting circulation of blood
US5554103 *Feb 27, 1995Sep 10, 1996Vasomedical, Inc.High efficiency external counterpulsation apparatus and method for controlling same
US5671751 *Mar 21, 1995Sep 30, 1997Lrc Holding Company, Inc.Medical pumping apparatus
US5769801 *Oct 7, 1994Jun 23, 1998Ndm Acquisition Corp.For applying compressive pressures against a patient's foot
US5840049 *Sep 7, 1995Nov 24, 1998Kinetic Concepts, Inc.Medical pumping apparatus
US5931160 *Dec 8, 1995Aug 3, 1999Cardiopulmonary CorporationVentilator control system and method
US5931797 *Dec 23, 1997Aug 3, 1999Kinetic Concepts, Inc.Medical pumping apparatus
US6119043 *Aug 5, 1998Sep 12, 2000Cardiac Pacemakers, Inc.Atrial and ventricular cardiac lead having a mechanical bias
US6152954 *Jul 22, 1998Nov 28, 2000Cardiac Pacemakers, Inc.Single pass lead having retractable, actively attached electrode for pacing and sensing
US6158432 *Mar 20, 1998Dec 12, 2000Cardiopulmonary CorporationVentilator control system and method
US6179793Jan 14, 1998Jan 30, 2001Revivant CorporationCardiac assist method using an inflatable vest
US6195759 *Oct 20, 1997Feb 27, 2001Intel CorporationMethod and apparatus for operating a synchronous strobe bus
US6345204Sep 14, 2000Feb 5, 2002Cardiac Pacemakers, Inc.Single pass lead having retractable, actively attached electrode for pacing and sensing
US6463930Jan 22, 2001Oct 15, 2002James W. BiondiSystem for automatically weaning a patient from a ventilator, and method thereof
US6572621Nov 8, 1999Jun 3, 2003Vasomedical, Inc.High efficiency external counterpulsation apparatus and method for controlling same
US6584973Sep 13, 2000Jul 1, 2003Cardiopulmonary CorporationVentilator control system and method
US6589267Nov 10, 2000Jul 8, 2003Vasomedical, Inc.High efficiency external counterpulsation apparatus and method for controlling same
US6620116Dec 8, 2000Sep 16, 2003Michael P. LewisExternal counterpulsation unit
US6668829Sep 30, 2002Dec 30, 2003Cardiopulmonary CorporationSystem for automatically weaning a patient from a ventilator, and method thereof
US6752771Jan 29, 2001Jun 22, 2004Revivant CorporationCardiac assist method using an inflatable vest
US6915169Oct 4, 2002Jul 5, 2005Cardiac Pacemakers, Inc.Extendable and retractable lead having a snap-fit terminal connector
US6962599Nov 9, 2001Nov 8, 2005Vasomedical, Inc.High efficiency external counterpulsation apparatus and method for controlling same
US6983185Jul 31, 2002Jan 3, 2006Cardiac Pacemakers, Inc.Lead with terminal connector assembly
US7017574Nov 17, 2003Mar 28, 2006Cardiopulmonary CorporationSystem for automatically weaning a patient from a ventilator, and method thereof
US7048702Jul 3, 2002May 23, 2006Vasomedical, Inc.External counterpulsation and method for minimizing end diastolic pressure
US7244225Oct 7, 2003Jul 17, 2007Cardiomedics, Inc.Devices and methods for non-invasively improving blood circulation
US7314478Jan 31, 2005Jan 1, 2008Vasomedical, Inc.High efficiency external counterpulsation apparatus and method for controlling same
US7334578Mar 27, 2006Feb 26, 2008Cardiopulmonary CorporationSystem for automatically weaning a patient from a ventilator, and method thereof
US7392095Jul 1, 2005Jun 24, 2008Cardiac Pacemakers, Inc.Extendable and retractable lead having a snap-fit terminal connector
US7774934Dec 8, 2005Aug 17, 2010Cardiac Pacemakers, Inc.Method for making a terminal connector
US7981066May 24, 2006Jul 19, 2011Michael Paul LewisExternal pulsation treatment apparatus
US8002718 *Jun 30, 2006Aug 23, 2011Siemens AktiengesellschaftShockwave system control dependent on patient's blood pressure
US8114037Jun 20, 2007Feb 14, 2012Michael Paul LewisHydraulically actuated external pulsation treatment apparatus
US8209035Jun 23, 2008Jun 26, 2012Cardiac Pacemakers, Inc.Extendable and retractable lead having a snap-fit terminal connector
US8285398Jul 7, 2010Oct 9, 2012Cardiac Pacemakers, Inc.Lead with terminal connector assembly
USRE42958 *Jul 17, 2009Nov 22, 2011Cardiomedics, Inc.Devices and methods for non-invasively improving blood circulation
EP0081051A1 *Sep 28, 1982Jun 15, 1983Dornier GmbhReleasing device for shock waves for therapeutic purposes
EP0514204A1 *May 15, 1992Nov 19, 1992Lcr Holding Company, Inc.Apparatus fo cyclically applying pressure to a body part
EP1435892A2 *Sep 20, 2002Jul 14, 2004Living Data Technology ApparatusExternal counter pulsation apparatus
WO1989009041A1 *Mar 31, 1989Oct 5, 1989Cardiopulmonary CorpCirculatory assist method and apparatus
WO1999036028A1Sep 18, 1998Jul 22, 1999Cardiologic Systems IncCardiac assist method using an inflatable vest
Classifications
U.S. Classification601/150
International ClassificationA61B5/0285, A61H23/04, A61H7/00, A61H31/00, A61B5/0402
Cooperative ClassificationA61H2230/04, A61B5/0285, A61H9/0078
European ClassificationA61H9/00P6, A61B5/0285
Legal Events
DateCodeEventDescription
Mar 21, 1988ASAssignment
Owner name: INTERMEDICS, INC.
Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:MAY PARTNERSHIP, THE, BY: ROLLINS HOLDING COMPANY, INC.;REEL/FRAME:004874/0945
Effective date: 19870112
Aug 25, 1986ASAssignment
Owner name: AMERICAN PACEMAKER CORPORATION A CORP OF MA
Owner name: AMERICAN PACEMAKER CORPORATION, A MASSACHUSETTS CO
Owner name: CALCITEK, INC., A TEXAS CORP.
Owner name: CALCITEK, INC., ALL TEXAS CORPS
Owner name: CARBO-MEDICS, INC.
Owner name: CARBOMEDICS, INC., A TEXAS CORP.
Effective date: 19860813
Owner name: INTERMEDICS CARDIASSIST, INC.
Owner name: INTERMEDICS CARDIASSIST, INC., A TEXAS CORP.
Owner name: INTERMEDICS INTRAOCULAR, INC.
Owner name: INTERMEDICS INTRAOCULAR, INC., A TEXAS CORP.
Effective date: 19860813
Owner name: INTERMEDICS, INC.
Owner name: INTERMEDICS, INC., A TEXAS CORP.
Owner name: NEUROMEDICS, INC.
Owner name: NEUROMEDICS, INC., A TEXAS CORP.
Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607
Effective date: 19860813
Owner name: SURGITRONICS CORPORATION
Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:CHASE COMMERCIAL CORPORATION;REEL/FRAME:004605/0581
Effective date: 19860804
Owner name: SURGITRONICS CORPORATION, A TEXAS CORP.
Owner name: INTERMEDICS INTRAOCULAR, INC., A TEXAS CORP., STAT
Owner name: CARBOMEDICS, INC., A TEXAS CORP., STATELESS
Owner name: INTERMEDICS CARDIASSIST, INC., A TEXAS CORP., STAT
Owner name: SURGITRONICS CORPORATION, A TEXAS CORP., STATELESS
Owner name: INTERMEDICS, INC., A TEXAS CORP., STATELESS
Owner name: NEUROMEDICS, INC., A TEXAS CORP., STATELESS
Owner name: CALCITEK, INC., A TEXAS CORP., STATELESS
Jul 8, 1986ASAssignment
Owner name: MAY PARTNERSHIP THE, 2170 PIEDMONT ROAD, N.E., ATL
Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC.,;INTERMEDICS CARDIASSIST, INC.;SURGITRONICS CORPORATION;AND OTHERS;REEL/FRAME:004581/0501
Effective date: 19860703
Owner name: MAY PARTNERSHIP, THE,GEORGIA
Jun 9, 1986ASAssignment
Owner name: INTERMEDICS, INC.
Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:CITICORP MULTILEASE (SEF), INC.;REEL/FRAME:004576/0516
Effective date: 19860515
Owner name: INTERMEDICS, INC., INTERMEDICS CARDIASSIST, INC.,
Free format text: SECURED PARTY HEREBY RELEASE THE SECURITY INTEREST IN AGREEMENT RECORDED AUGUST 5, 1985. REEL 4434 FRAMES 728-782;ASSIGNOR:CITIBANK, N.A.;REEL/FRAME:004592/0394
Effective date: 19860502
Free format text: SAID PARTIES RECITES OBLIGATIONS RECITED IN SECURITY AGREEMENT RECORDED SEPTEMBER 17, 1984 REEL 4303 FRAMES 077-127 HAVE BEEN PAID IN FULL ALL;ASSIGNOR:CITIBANK, N.A., INDIVIDUALLY AND AS AGENT FOR BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION, THE CHASE MANHATTAN BANK, N.A., THE FIRST NATIONAL BANK OF CHICAGO, TRUST COMPANY BANK, FIRST FREEPORT NATIONAL BANK OF BRAZOSPORT BANK OF TEXAS;REEL/FRAME:004592/0424
Aug 5, 1985AS06Security interest
Owner name: CHASE COMMERCIAL CORPORATION
Owner name: INTERMEDICS CARDIASSIST, INC., A CORP OF T
Owner name: INTERMEDICS, INC., A CORP. OF TEXAS
Effective date: 19850703
Aug 5, 1985ASAssignment
Owner name: B.A. LEASING CORPORATION
Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC., A CORP. OF TEXAS;INTERMEDICS CARDIASSIST, INC.;INTERMEDICS INTRAOCULAR, INC., A CORP. OF TEXAS;AND OTHERS;REEL/FRAME:004449/0424
Owner name: CHASE COMMERCIAL CORPORATION
Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC., A CORP. OF TEXAS;INTERMEDICS CARDIASSIST, INC., A CORP OF TX.;INTERMEDICS INTRAOCULAR, INC., A CORP. OF TEXAS;AND OTHERS;REEL/FRAME:004449/0501
Effective date: 19850703
Owner name: CITIBANK, N.A.
Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC., A TX CORP;INTERMEDICS CARDIASSIST, INC., A TX CORP.;INTERMEDICS INTRAOCULAR, INC., A TX CORP.;AND OTHERS;REEL/FRAME:004434/0728
Owner name: CITICORP MILTILEASE (SEF), INC.
Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC.;INTERMEDICS CARDIASSIST, INC.;INTERMEDICS INTRAOCULAR, INC., A CORP. OF TEXAS;AND OTHERS;REEL/FRAME:004452/0900
Sep 17, 1984ASAssignment
Owner name: BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIA
Owner name: BRAZOSPORT BANK OF TEXAS
Owner name: CHASE MANHATTAN BANK, N.A., THE
Owner name: CITIBANK, N.A., AS AGENT
Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC.;INTERMEDICS CARDIASSIST, INC.;INTERMEDICS INTRAOCULAR, INC.;AND OTHERS;REEL/FRAME:004303/0077
Effective date: 19840726
Owner name: FIRST FREEPORT NATIONAL BANK
Owner name: FIRST NATIONAL BANK OF CHICAGO, THE
Owner name: TRUST COMPANY BANK
Jul 22, 1982ASAssignment
Owner name: INTERMEDICS CARDIASSIST, INC., 240 TARPON INN VILL
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:CARDIASSIST CORPORATION;REEL/FRAME:004015/0042
Effective date: 19820528
Jul 22, 1982AS02Assignment of assignor's interest
Owner name: CARDIASSIST CORPORATION
Owner name: INTERMEDICS CARDIASSIST, INC., 240 TARPON INN VILL
Effective date: 19820528